When Ashgate Publishing was bought last summer by Informa, a large corporation, some academics feared for its future. What would happen to the family-owned publishing house, which had spent four decades building a reputation for social responsibility and close relationships with its authors?
In November those fears started coming true. According to a Change.org petition called "Save Ashgate Publishing," Informa has shuttered Ashgate’s U.S. office, putting several editors out of their jobs. There are rumors that their counterparts in England might soon suffer a similar fate.
"Academic presses are more than profit margins, income from the backlist, utility bills, payroll, and marketing campaigns," wrote the petitioners, who have collected 7,000 signatures online.
Informa, a company that also organizes trade shows and sells "business intelligence" products, has become the latest adversary for academics worried about consolidation in academic publishing. The company’s scholarly-publishing division is its biggest moneymaker, accounting for $616 million of Informa’s $1.7 billion in revenue in 2014. The Taylor & Francis Group, an Informa subsidiary, has bought a number of smaller publishers over the years, and it now has thousands of books and journals under its umbrella.
"For them to go out and acquire another publisher, in this case Ashgate, is just part of the playbook," says Joseph Esposito, a consultant who specializes in academic publishing. "And for them to try to consolidate the operations in order to save on costs is, again, just part of the playbook."
That playbook might make sense to Informa’s business-intelligence customers, but to some academics it reads more like a doomsday plot. Universities have long clashed with commercial publishers over the fees those companies charge for access to works that the universities have, in essence, already paid for — by employing the professors who researched, wrote, and reviewed them. But consolidation has allowed big publishers like Elsevier to retain a balance of power that allows them to continue turning huge profits while conceding relatively little to academe.
Critics now worry that Informa, which is a publicly traded company, will respect the desires of its shareholders more than those of the scholars who supply its product.
The trend toward consolidation is not all bad for academics, says Mr. Esposito. A powerful publisher can get a relatively obscure monograph into more libraries or make it easier to discover online. "You now have a global footprint for sales and marketing," he says. "Most authors like that."
Then again, the publisher might force the researcher’s library to pay for books it does not necessarily want as part of a package deal.
For Ashgate’s authors the promise of a "global footprint" might not be worth the cost. The petition to "save" the publishing house mentions the names of editors who it says were laid off when Informa closed Ashgate’s U.S. office.
"Ashgate flourished," it says, "through the bonds formed between editors and authors, the care and attention of copy editors, and above all, the good will of authors and readers."
In her essay Ms. Kennedy urged other academic presses to hire those editors.
"We who are Ashgate (and that is clearly a lot of us) may flourish elsewhere, but only if we work hard to leverage our networks to make these rehomings possible," she wrote. "Our networks are what make a press valuable to us, and those we carry with us."